Key result
Image-based virtual-heart ablation targets (VAAT) were spatially concordant with ECG-based predicted VT exit sites (PAVEL), with a mean distance of 10.7 ± 7.3 mm between them.
Why the study?
To test whether image-based VAAT and ECG-based PAVEL noninvasive technologies are spatially concordant in their predictions for VT ablation targeting in ischemic cardiomyopathy patients.
Are image-based virtual-heart ablation targets (VAAT) spatially concordant with predicted ECG-based arrhythmia exit-sites (PAVEL) in ischemic cardiomyopathy patients?
Observational (n=4)
Are image-based virtual-heart ablation targets (VAAT) spatially concordant with predicted ECG-based arrhythmia exit-sites (PAVEL) in ischemic cardiomyopathy patients?
Image-based virtual-heart ablation targets and ECG-based arrhythmia exit-site predictions show spatial concordance, supporting their combined use as a noninvasive tool for VT ablation targeting.
Answers are grounded in this paper and cite their sources.
Supports combined noninvasive VT targeting in ischemic cardiomyopathy; hypothesis-generating from case report data requiring prospective validation.
INTRODUCTION: We recently developed two noninvasive methodologies to help guide VT ablation: population-derived automated VT exit localization (PAVEL) and virtual-heart arrhythmia ablation targeting (VAAT). We hypothesized that while very different in their nature, limitations, and type of ablation targets (substrate-based vs. clinical VT), the image-based VAAT and the ECG-based PAVEL technologies would be spatially concordant in their predictions. OBJECTIVE: The objective is to test this hypothesis in ischemic cardiomyopathy patients in a retrospective feasibility study. METHODS: Four post-infarct patients who underwent LV VT ablation and had pre-procedural LGE-CMRs were enrolled. Virtual hearts with patient-specific scar and border zone identified potential VTs and ablation targets. Patient-specific PAVEL based on a population-derived statistical method localized VT exit sites onto a patient-specific 238-triangle LV endocardial surface. RESULTS: Ten induced VTs were analyzed and 9-exit sites were localized by PAVEL onto the patient-specific LV endocardial surface. All nine predicted VT exit sites were in the scar border zone defined by voltage mapping and spatially correlated with successful clinical lesions. There were 2.3 ± 1.9 VTs per patient in the models. All five VAAT lesions fell within regions ablated clinically. VAAT targets correlated well with 6 PAVEL-predicted VT exit sites. The distance between the center of the predicted VT-exit-site triangle and nearest corresponding VAAT ablation lesion was 10.7 ± 7.3 mm. CONCLUSIONS: VAAT targets are concordant with the patient-specific PAVEL-predicted VT exit sites. These findings support investigation into combining these two complementary technologies as a noninvasive, clinical tool for targeting clinically induced VTs and regions likely to harbor potential VTs.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2021) conducted an observational in Ischemic cardiomyopathy (n=4). VAAT and PAVEL methodologies was evaluated on Spatial concordance between VAAT targets and PAVEL-predicted VT exit sites. Image-based virtual-heart ablation targets (VAAT) were spatially concordant with ECG-based predicted VT exit sites (PAVEL), with a mean distance of 10.7 ± 7.3 mm between them.
Synapse has enriched 10 related papers. Consider them for comparative context: